Picture of S2Medical AB (publ) logo

S2M S2Medical AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: S2Medical Reports Positive Results For Eiratex In Biocompatibility Study

Oct 22 (Reuters) - S2Medical AB (publ)  S2ME.ST :
    * POSITIVE RESULTS FOR EIRATEX IN BIOCOMPATIBILITY STUDY
    * RESULTS OF THE TESTS CONFIRMED THAT MATERIAL DOES NOT
CAUSE ANY
SIGNS OF SYSTEMIC TOXICITY AND THUS ACHIEVES THE HIGHEST LEVEL
OF BIOCOMPATIBILITY
    * MATERIAL EIRATEX WHICH IS THE BASIS OF CO'S PRODUCT
EPIPROTECT
MEETS REQUIREMENTS FOR SUBCHRONIC TOXICITY IN ACCORDANCE WITH
ISO10993-11: 2017
    * TOGETHER WITH OTHER TESTS IN THE STUDY, THIS RESULT
CONFIRMS THE
POTENTIAL OF THE MATERIAL AS AN IMPLANT

Source text for Eikon:  ID:nWkr2lNvS 
Further company coverage:  S2ME.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on S2Medical AB (publ)

See all news